Harvard Management Company’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-314,762
| Closed | -$3.14M | – | 27 |
|
|
2023
Q2 | $3.14M | Hold |
314,762
| – | – | 0.31% | 16 |
|
|
2023
Q1 | $2.8M | Hold |
314,762
| – | – | 0.29% | 29 |
|
|
2022
Q4 | $3.46M | Hold |
314,762
| – | – | 0.43% | 27 |
|
|
2022
Q3 | $4.1M | Hold |
314,762
| – | – | 0.51% | 25 |
|
|
2022
Q2 | $3.99M | Hold |
314,762
| – | – | 0.46% | 25 |
|
|
2022
Q1 | $4.41M | Hold |
314,762
| – | – | 0.45% | 30 |
|
|
2021
Q4 | $9.11M | Hold |
314,762
| – | – | 0.86% | 20 |
|
|
2021
Q3 | $9.43M | Hold |
314,762
| – | – | 0.55% | 25 |
|
|
2021
Q2 | $8.35M | Hold |
314,762
| – | – | 0.48% | 25 |
|
|
2021
Q1 | $9.79M | Hold |
314,762
| – | – | 0.55% | 24 |
|
|
2020
Q4 | $10.3M | Hold |
314,762
| – | – | 0.56% | 17 |
|
|
2020
Q3 | $11M | Buy |
+314,762
| New | +$11M | 0.6% | 16 |
|